What is the best treatment for a patient with a herpetic lesion on the nose?

Treatment of Herpetic Lesion on the Nose

For a herpetic lesion on the nose, immediate ophthalmology referral is mandatory to rule out herpes zoster ophthalmicus, and treatment should be initiated with oral valacyclovir 1000 mg three times daily for 7-10 days, starting within 72 hours of rash onset. 1, 2

Critical Initial Assessment

The location on the nose raises immediate concern for herpes zoster ophthalmicus (HZO), which can cause vision-threatening complications including keratitis, uveitis, and permanent vision loss. 1, 3

Determine the Viral Etiology

Herpes Zoster (Shingles):

• Unilateral vesicular eruption following a dermatomal distribution, often with preceding pain 24-72 hours before rash onset 4
• Lesions on the nose, particularly the tip (Hutchinson's sign), indicate nasociliary nerve involvement and high risk of ocular complications 1, 3
• Requires immediate ophthalmology evaluation within 1 week, including visual acuity measurement and slit-lamp biomicroscopy 1

Herpes Simplex Virus (HSV):

• Grouped vesicles or ulcers on an erythematous base, typically without dermatomal distribution 5
• May present as recurrent lesions in the same location 5
• Less commonly causes severe ocular complications than HZO, but still requires vigilance 6

Treatment Algorithm

For Herpes Zoster Ophthalmicus (Most Likely Given Nasal Location)

First-Line Treatment:

• Oral valacyclovir 1000 mg three times daily for 7-10 days is preferred over acyclovir due to superior bioavailability, convenience, and equivalent efficacy 1, 7, 8
• Alternative: Oral acyclovir 800 mg five times daily for 7-10 days 2, 9
• Treatment must begin within 72 hours of rash onset for maximum efficacy in preventing ocular complications and post-herpetic neuralgia 1, 10, 3
• Continue treatment until all lesions have completely scabbed, not just for an arbitrary 7-day period 1, 2

Escalation Criteria for Intravenous Therapy:

• Multi-dermatomal involvement or disseminated disease 1, 2
• Confirmed ocular complications (keratitis, uveitis, optic neuritis) 1
• Immunocompromised status 1, 2
• CNS involvement or visceral complications 2
• Dose: Intravenous acyclovir 10 mg/kg every 8 hours 2

For Herpes Simplex Virus (Less Likely but Possible)

If HSV is confirmed:

• Oral acyclovir 400 mg five times daily for 5-10 days OR 200 mg five times daily for 7-10 days 11, 9
• Alternative: Oral valacyclovir 500 mg twice daily 6
• Topical antivirals alone are inadequate and should not be used as monotherapy 11, 5

If ocular involvement is present with HSV:

• Combination therapy is mandatory: topical antiviral (ganciclovir 0.15% gel three to five times daily OR trifluridine 1% solution five to eight times daily) PLUS oral antiviral 6, 1
• Oral antivirals alone are insufficient to prevent progression of HSV corneal disease 6, 1

Absolute Contraindications

Topical corticosteroids are absolutely contraindicated in active HSV epithelial disease, as they potentiate viral replication and worsen infection. 6, 1 However, for herpes zoster, corticosteroids may be considered as adjunctive therapy in select cases, though this remains controversial and should only be done under specialist guidance. 2

Mandatory Ophthalmology Referral

All patients with herpetic lesions on the nose require immediate ophthalmology evaluation to assess for:

• Keratitis (dendritic ulcers, stromal involvement) 6, 1
• Uveitis 6, 1
• Elevated intraocular pressure 6
• Cranial nerve palsies 6

Follow-up should occur within 1 week and include visual acuity measurement and slit-lamp biomicroscopy. 6, 1

Special Populations

Immunocompromised patients:

• Require higher doses and potentially intravenous therapy: acyclovir 10 mg/kg IV every 8 hours 1, 2
• Treatment duration may need extension beyond 7-10 days until complete lesion resolution 2
• Consider temporary reduction in immunosuppressive medications for disseminated disease 2

Pregnant women:

• Varicella-zoster immune globulin (VZIG) should be given within 96 hours if exposed and susceptible 12, 2
• Oral antivirals can be used for active infection, with individualized risk-benefit assessment 12

Common Pitfalls to Avoid

• Do not delay treatment waiting for laboratory confirmation - initiate therapy based on clinical presentation within 72 hours of rash onset 1, 10, 3
• Do not use topical antivirals as monotherapy - they are substantially less effective than systemic therapy 2, 11, 5
• Do not stop treatment at exactly 7 days if lesions are still active - continue until complete scabbing occurs 1, 2
• Do not miss ophthalmology referral - nasal involvement carries high risk of vision-threatening complications 1, 3
• Do not use topical corticosteroids in HSV epithelial disease - this is an absolute contraindication 6, 1

Monitoring During Treatment

• Assess for new lesion formation and progression of existing lesions 2
• Monitor renal function if using intravenous acyclovir, with dose adjustments for renal impairment 2, 7
• If lesions fail to improve within 7-10 days, suspect acyclovir resistance and obtain viral culture with susceptibility testing 2
• For acyclovir-resistant cases, foscarnet 40 mg/kg IV every 8 hours is the treatment of choice 2